62K-20932-23390
2 vaccinations
5 coded responses
21 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 325 / FL
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
-
2020-12-30
Survey response — day 0, dose 1MedDRA: Hyperhidrosis — Feeling: GoodFree text: Profuse sweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-04
- 2021-01-05
- 2021-01-09
- 2021-01-13
- 2021-01-22
-
2021-01-26
Dose 2 — Moderna
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tirednessFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
- 2021-02-02
- 2021-02-11
- 2021-02-16
- 2021-02-25
- 2021-03-02
- 2021-03-09
-
2021-04-27
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Common coldMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-27
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-01-26
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-04-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-26 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-27 | Unsuccessful |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Profuse sweating
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes
Release 8 — 3 months, dose 2
Symptoms: Common cold
Release 9 — 6 months, dose 2
Symptoms: Pregnancy
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release